Adrian Hill of the University of Oxford in the United Kingdom, one of the original Grand Challenges in Global Health grantees, has developed a viral-vectored malaria vaccine candidate that is currently in Phase II trials. Learn more about this innovative project and its potential to save millions of lives in the developing world.